首页> 外文OA文献 >Isolation and Purification of a New Kalimantacin/Batumin-Related Polyketide Antibiotic and Elucidation of Its Biosynthesis Gene Cluster
【2h】

Isolation and Purification of a New Kalimantacin/Batumin-Related Polyketide Antibiotic and Elucidation of Its Biosynthesis Gene Cluster

机译:新型卡利米他滨/巴他汀相关聚酮化合物抗生素的分离纯化及其生物合成基因簇的阐明

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Kal/bat, a polyketide, isolated to high purity (>95%) is characterized by strong and selective antibacterial activity against Staphylococcus species (minimum inhibitory concentration, 0.05 mug/mL), and no resistance was observed in strains already resistant to commonly used antibiotics. The kal/bat biosynthesis gene cluster was determined to a 62 kb genomic region of Pseudomonas fluorescens BCCM_ID9359. The kal/bat gene cluster consists of 16 open reading frames (ORF), encoding a hybrid PKS-NRPS system, extended with trans-acting tailoring functions. A full model for kal/bat biosynthesis is postulated and experimentally tested by gene inactivation, structural confirmation (using NMR spectroscopy), and complementation. The structural and microbiological study of biosynthetic kal/bat analogs revealed the importance of the carbamoyl group and 17-keto group for antibacterial activity. The mechanism of self-resistance lies within the production of an inactive intermediate, which is activated in a one-step enzymatic oxidation upon export. The genetic basis and biochemical elucidation of the biosynthesis pathway of this antibiotic will facilitate rational engineering for the design of novel structures with improved activities. This makes it a promising new therapeutic option to cope with multidrug-resistant clinical infections.
机译:Kal / bat,一种高纯度(> 95%)的聚酮化合物,其特征在于对葡萄球菌具有强而有选择性的抗菌活性(最低抑菌浓度,0.05杯/毫升),在已经对常用菌株产生抗药性的菌株中未观察到抗药性抗生素。 kal / bat生物合成基因簇被确定为荧光假单胞菌BCCM_ID9359的62 kb基因组区域。 kal / bat基因簇由16个开放阅读框(ORF)组成,编码一个混合的PKS-NRPS系统,并扩展了反式剪裁功能。通过基因失活,结构确认(使用NMR光谱法)和互补作用,提出了Kal / bat生物合成的完整模型并进行了实验测试。生物合成的kal / bat类似物的结构和微生物学研究表明,氨基甲酰基和17-酮基对抗菌活性很重要。自抗性的机理在于无活性中间体的产生,该中间体在出口时以一步酶促氧化的方式被活化。这种抗生素的生物合成途径的遗传基础和生化方法的阐明,将有助于进行合理的工程设计,以设计具有改进活性的新型结构。这使其成为应对多药耐药性临床感染的有希望的新治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号